Latest Breaking News On - Josep sol - Page 1 : comparemela.com

Aktiia Secures USD 30M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Daniel grafMattia bertschiJosep solSwitzerland based healthtechKhosla venturesTranslink capital

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Daniel grafJosep solMattia bertschiPrnewswire aktiiaAssad khanSwiss healthtechKhosla venturesTranslink capital

Daniel Graf joins Aktiia as the new President and Independent Board Member

/PRNewswire/ Daniel Graf has joined Aktiia in the role of President and Independent Board Member. Daniel has an extraordinary career trajectory, known for.

Mattia bertschiPrnewswire danielJosep solIndependent boardVice presidentGoogle maps

Cuffless Blood Pressure Monitors: Still a Numbers Game

Despite excitement on the part of clinicians and patients for these user-friendly devices, many experts question their accuracy and say they re not ready for routine use.

Columbia centerNew yorkUnited statesIsrael generalJeremy kahnTimothyb planteJay shahLior ben shettritDaichi shimboEdward lifesciencesEric topolJosep solGeorge institute for global healthInstitute of electricalHadassah ein kerem medical centerAmerican heart association statement

Aktiia blood pressure wearable matches cuff in new study

Aktiia, the cuffless blood pressure tracking wearable, has shown comparable results to traditional cuff, a new study has revealed.

Josep solHypertension research